The effect of intravenous antibiotics on anaemia in cystic fibrosis  by Kathiresan, Bhuvaneswari et al.
www.elsevier.com/locate/jcf
Journal of Cystic Fibrosis 12 (2013) 828–829Letter to the Editor
The effect of intravenous antibiotics on anaemia in cystic ﬁbrosis
Bhuvaneswari Kathiresan ⁎, David Waine, David Derry
Plymouth Hospitals NHS Trust, United Kingdom
Received 22 February 2013; accepted 25 February 2013
Available online 2 April 2013
Keywords: Anaemia; Chronic disease; Cystic ﬁbrosis; HepcidinTable 1
Table showing median rise of haemoglobin in anaemic and non-anaemic groups
on treatment with intravenous antibiotic for their infective exacerbations.
Reason for admission Median increase in
haemoglobin (g/dl)
(n = number of admissions)
p-value
Infective exacerbation +0.7 (51) b0.001
Anaemic on admission
Infective exacerbation +0.2 (105) 0.047
Not anaemic on admission a
Infective exacerbation +0.6 (21) 0.005
- Anaemic on admission
- On iron supplements
Infective exacerbation +0.7 (30) b0.001
- Anaemic on admission
- Not on iron supplements
Other, varied reasons for admission, −1.6 (8)The report by Hoo and Wildman [1] of their experience of
parenteral iron infusions makes cautionary reading. Traditional
measure of iron deficiency (serum iron, ferritin, transferrin,
transferrin saturation) does not distinguish between “true” iron
deficient anaemia and the anaemia of chronic disease caused by
the physiological restriction of iron [2].
Dietary iron is absorbed by duodenal enterocytes. It is released
into the circulation by the iron exporter protein, ferroportin.
When ferroportin activity is low, iron accumulates in enterocytes
and is lost when old enterocytes are sloughed into the gut lumen.
Ferroportin on the surface ofmacrophages regulates the release of
iron, which is recycled when aged red blood cells are destroyed.
Ferroportin activity is controlled by hepcidin, a peptide produced
by the liver, which also has anti-microbial activity. Hepcidin
causes ferroportin internalisation and degradation. So, when
hepcidin levels are high, iron accumulates in enterocytes and
macrophages, restricting availability to erythropoietic cells and
resulting in anaemia [4,5]. Hepcidin levels fall in response to
anaemia and hypoxaemia, but increase in response to high levels
of interleukin-6 (IL6) found in infection and inflammation [3,4].
Suppressing this inflammatory response will reduce hepcidin and
increase iron availability. Therefore, we tested whether treatment
of exacerbations with antibiotics resulted in an increase in
haemoglobin, without the use of intravenous iron.
200 consecutive admissions of patients between January 2008
and January 2013 with cystic fibrosis were analysed. Haemoglobin
concentrations in blood samples taken nearest the admission
and discharge dates were compared. Admissions were divided
according to reason for admission, and subdivided according to
the presence of anaemia on admission and whether the patient
was already on oral iron supplements at time of admission. Many
admissions for reasons other than treatment of infective exacerba-
tions were brief and only 1 blood sample had been taken and so⁎ Corresponding author.
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admissions in total (156 with infective exacerbation & 8 with
other reasons). No patient was commenced on iron supplements
during an acute admission.
51 admissions had anaemia and 105 had no anaemia on
admission during infective exacerbation over the study period.
In the anaemic group the median rise of haemoglobin (Hb) was
0.7(g/dl) (paired t-test, p b 0.001). In the non-anaemic group the
median rise of Hb was 0.2(g/dl) (paired t-test, p-value 0.047)
(Table 1).
The median rise in Hb in the anaemic group who were on iron
(n = 21) was 0.6 (paired t-test, p = 0.005), compared to a rise of
0.7 in the anaemic group not on oral iron (paired t-test, p b0.001)
and there was no statistical difference between the 2 groups
(independent t-test, p = 0.476).
Hoo and Wildman do not detail how they assessed iron
deficiency, but the magnitude of improvement in haemoglobin,but not for treatment of infection
a 11 admissions occurred to non-anaemic patients receiving oral iron; results
are similar whether receiving iron or not.
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829Letter to the Editorwhich they attributed to parenteral iron, we have observed in
anaemic CF patients, treatedwith intravenous antibiotics alone.We
propose that the improvement in haemoglobin is a consequence
of the increased availability of iron that results from a reduction
in infection, IL6 and hepcidin.
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